scholarly journals Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units

2017 ◽  
Vol Volume 12 ◽  
pp. 783-784 ◽  
Author(s):  
Huriye Berk Takir ◽  
Antonio Esquinas
2021 ◽  
pp. 22-24
Author(s):  
Ikbal Ali ◽  
Ajith Kumar M S ◽  
Mahendra Kumar Meena ◽  
Agnihotri SP

BACKGROUND: Cardiovascular disease is one of the major causes of mortality and is frequently unrecognized in COPD patients. Serum N-terminal pro-brain natriuretic peptide (NT-pro BNP) is an established risk factor in patients with Heart failure. However NT-pro BNP levels may also be elevated during acute exacerbation of COPD(AECOPD) even without heart failure. Objectives of the study are-(a)To nd the levels of Serum NT-pro BNP in AECOPD patients. (b) To nd out the association of Serum NT-pro BNP with clinical and physiological parameters in AECOPD patients. METHODS: This cross-sectional study was carried out on 60 AECOPD patients admitted in department of Respiratory Medicine, Institute of Respiratory Diseases, SMS Medical College, Jaipur during July 2019–June 2020. Clinical data including vitals, Electrocardiogram (ECG), arterial blood gas analysis (ABG), Serum NT-pro BNP levels were assessed. Previous ECG and spirometry details were also recorded. RESULTS: The mean levels of Serum NT-pro BNP were higher in very severe COPD patients. The association of Serum NT-pro BNP were signicantly higher with AECOPD patients having increased exacerbations per year, longer hospital stay duration, decreasing Spo2 levels and decreasing blood pH levels. CONCLUSION: Patients with AECOPD who had elevated Serum NT-pro BNP levels had higher likelihood of ICU admission and longer hospital stay. Thus elevated NT-pro BNP levels warrants the need of Intensive care for early and better management of COPD patients.


2021 ◽  
pp. 6-8
Author(s):  
Gyan Singh Meena ◽  
Ajith Kumar M S ◽  
Shashank Sharma ◽  
SP Agnihotri

BACKGROUND: Acute exacerbation of COPD (AECOPD) is one of the most common cause of hospital admission. It causes signicant morbidity, mortality and inexorable decline in ling function. Many exacerbations are believed to be due to upper and/ lower respiratory tract viral infections, but the incidence of these infections in patients with COPD is still undetermined. Objectives of the study are-(a) To nd out the viral etiology in patients having acute exacerbation of COPD. (b) To correlate the severity of COPD patients having exacerbations with viral etiology. METHODS: This cross-sectional study was carried out on 70 AECOPD patients admitted in department of Respiratory Medicine, Institute of Respiratory Diseases, SMS Medical College, Jaipur during July 2019–June 2020. Demographic and clinical parameters were recorded from each patient during admission. Twin nasopharyngeal/oropharyngeal swabs were collected and are tested for Respiratory viruses via RT-PCR. RESULTS: Respiratory viruses were detected in 15 of 70 (21.42%) patients during exacerbations of COPD. The viruses detected were inuenza (10%), rhinovirus (5.71%), adenovirus (4.29%) and RSV (1.42%). Majority of the patients had exacerbations in severe COPD subgroup, had duration of hospital stay of more than or equal to 5 days, had one episode of acute exacerbation per year and 5, 9, 11 respiratory viruses were detected in this group respectively. CONCLUSION: Viral infections seem to contribute to the exacerbations of COPD in our settings and should be strongly considered in the management of such patients. Considering appropriate antiviral therapy can timely reduce morbidity in an event of an inuenza viral exacerbation.


CHEST Journal ◽  
2016 ◽  
Vol 149 (4) ◽  
pp. A343
Author(s):  
Xian Wen Sun ◽  
Qing Yun Li ◽  
Pei Li Chen ◽  
Lei Ni ◽  
Lei Ren ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document